Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bruce

Showing results (971-980 of 981) with videos related to

Pageof 99
Sort By:
Plos Biology|April 29, 2025
Variant mutation G215C in SARS-CoV-2 nucleocapsid enhances viral infection via altered genomic encapsidationHannah C Kubinski, Hannah W Despres, Bryan A Johnson, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2020
Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 <i>in vitro</i>Nir Drayman, Krysten A Jones, Saara-Anne Azizi, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|March 31, 2021
Two-phase survey on the frequency of use and safety of MRI for hearing implant recipientsPaul van de Heyning, Griet Mertens, Vedat Topsakal, et al.
Journal of Medical Genetics|April 21, 2021
Personalised virtual gene panels reduce interpretation workload and maintain diagnostic rates of proband-only clinical exome sequencing for rare disordersLeslie Patricia Molina-Ramírez, Claire Kyle, Jamie M Ellingford, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2021
Live Imaging of SARS-CoV-2 Infection in Mice Reveals Neutralizing Antibodies Require Fc Function for Optimal EfficacyIrfan Ullah, Jérémie Prévost, Mark S Ladinsky, et al.
Immunity|August 28, 2021
Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacyIrfan Ullah, Jérémie Prévost, Mark S Ladinsky, et al.
Science (New York, N.Y.)|July 21, 2021
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2Nir Drayman, Jennifer K DeMarco, Krysten A Jones, et al.
Gastroenterology|March 7, 2021
Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal SymptomsAlexandra E Livanos, Divya Jha, Francesca Cossarini, et al.
Physical Review Letters|July 1, 2017
Shape Evolution in Neutron-Rich Krypton Isotopes Beyond N=60: First Spectroscopy of ^{98,100}KrF Flavigny, P Doornenbal, A Obertelli, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
Surveillance of Vermont wildlife in 2021-2022 reveals no detected SARS-CoV-2 viral RNAHannah W Despres, Margaret G Mills, Madaline M Schmidt, et al.
Pageof 99

Showing results (971-980 of 981) with videos related to

Sort By:
Pageof 99
Plos Biology|April 29, 2025
Variant mutation G215C in SARS-CoV-2 nucleocapsid enhances viral infection via altered genomic encapsidationHannah C Kubinski, Hannah W Despres, Bryan A Johnson, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2020
Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 <i>in vitro</i>Nir Drayman, Krysten A Jones, Saara-Anne Azizi, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|March 31, 2021
Two-phase survey on the frequency of use and safety of MRI for hearing implant recipientsPaul van de Heyning, Griet Mertens, Vedat Topsakal, et al.
Journal of Medical Genetics|April 21, 2021
Personalised virtual gene panels reduce interpretation workload and maintain diagnostic rates of proband-only clinical exome sequencing for rare disordersLeslie Patricia Molina-Ramírez, Claire Kyle, Jamie M Ellingford, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2021
Live Imaging of SARS-CoV-2 Infection in Mice Reveals Neutralizing Antibodies Require Fc Function for Optimal EfficacyIrfan Ullah, Jérémie Prévost, Mark S Ladinsky, et al.
Immunity|August 28, 2021
Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacyIrfan Ullah, Jérémie Prévost, Mark S Ladinsky, et al.
Science (New York, N.Y.)|July 21, 2021
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2Nir Drayman, Jennifer K DeMarco, Krysten A Jones, et al.
Gastroenterology|March 7, 2021
Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal SymptomsAlexandra E Livanos, Divya Jha, Francesca Cossarini, et al.
Physical Review Letters|July 1, 2017
Shape Evolution in Neutron-Rich Krypton Isotopes Beyond N=60: First Spectroscopy of ^{98,100}KrF Flavigny, P Doornenbal, A Obertelli, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
Surveillance of Vermont wildlife in 2021-2022 reveals no detected SARS-CoV-2 viral RNAHannah W Despres, Margaret G Mills, Madaline M Schmidt, et al.
Pageof 99